A few weeks ago I blogged about a couple analysts cautioning investors that shares of Irish drugmaker Elan would be volatile surrounding the Alzheimer's conference the end of this month.That has certainly proven to be the case, especially today as the second firm this week initiates coverage of the stock, but this time with a "Sell" rating.   Read More

Genentech, the world's biggest biotech, releases its quarterly report on Monday. Will the sector get a boost from DNA earnings?   Read More

Big pharma makes strange bedfellows. Pfizer, Merck and Eli Lilly this morning announced they've launched a joint venture of sorts called, "Enlight Biosciences". They're doing it with the help of the Boston-based VC firm PureTech Ventures.    Read More

The right health care stocks can earn investors big bucks, said William Muggia, portfolio manager at Touchstone Mid Cap Growth Fund.    Read More

At the risk of being ganged up on by the "Elanians" who will take umbrage with the fact that the biopharma team at Cowen and Company is not initiating coverage of the Irish drugmaker with a "screaming buy," I am blogging about the analysts' 50-page call on the stock today.    Read More

So where should an investor's dollar go:  large-cap stocks, mid-caps, or small-caps? Try all three!   Read More

Ahead of the long holiday weekend I thought this would be as good a time as any to once again go through the "Pharma's Market" mailbag. A couple of blog readers complained about my "short" story about Amgen.   Read More

What are the best plays when the market enters bear territory?   Read More

Nearly 1.4 billion shares and $18 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge.  Check out the bets being made today...   Read More

Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now! Also, get your dice roll trades for those of you playing CNBC's Million Dollar Challenge.   Read More